New Publications

• 177Lu-octreotate therapy for neuroendocrine tumours is enhanced by Hsp90 inhibition.

  [1 Feb 2019] Hofving T, Sandblom V, Arvidsson Y, Shubbar E, Altiparmak G, Swanpalmer J, Almobarak B, Elf AK, Johanson V, Elias E, Kristiansson E, Forssell-Aronsson E, Nilsson O. Endocr Relat Cancer. 2019 Feb 1. pii: ERC-18-0509.R1. doi: 10.1530/ERC-18-0509. [Epub ahead of print] PMID: 30730850

• Univariate and classification analysis reveals potential diagnostic biomarkers for early stage ovarian cancer Type 1 and Type 2.

  [30 Jan 2019] Marci¿auskas S, Ulfenborg B, Kristjansdottir B, Waldemarson S, Sundfeldt K. J Proteomics. 2019 Jan 30;196:57-68. doi: 10.1016/j.jprot.2019.01.017. [Epub ahead of print] PMID: 30710757

• Multiparametric MR for non-invasive evaluation of tumour tissue histological characteristics after radionuclide therapy.

  [28 Jan 2019] Montelius M, Jalnefjord O, Spetz J, Nilsson O, Forssell-Aronsson E, Ljungberg M. NMR Biomed. 2019 Jan 28:e4060. doi: 10.1002/nbm.4060. [Epub ahead of print] PMID: 30693592

• Clinical, genetic and experimental studies of the Brooke-Spiegler (CYLD) skin tumor syndrome.

  [24 Jan 2019] Andersson MK, Kölby L, Nilsson JA, Stenman G. J Plast Surg Hand Surg. 2019 Jan 24:1-5. doi: 10.1080/2000656X.2018.1547736. [Epub ahead of print] PMID: 30676842

• Intra-Tumor DNA Methylation Heterogeneity in Glioblastoma; Implications for DNA Methylation-Based Classification.

  [22 Jan 2019] Wenger A, Ferreyra Vega S, Kling T, Olsson Bontell T, Jakola AS, Carén H. Neuro Oncol. 2019 Jan 22. doi: 10.1093/neuonc/noz011. [Epub ahead of print] PMID: 30668814

• JAK-STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma.

  [16 Jan 2019] Dolatabadi S, Jonasson E, Lindén M, Fereydouni B, Bäcksten K, Nilsson M, Martner A, Forootan A, Fagman H, Landberg G, Åman P, Ståhlberg A. Int J Cancer. 2019 Jan 16. doi: 10.1002/ijc.32123. [Epub ahead of print] PMID: 30650179

• The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia.

  [15 Jan 2019] Hallner A, Bernson E, Hussein BA, Sander FE, Brune M, Aurelius J, Martner A, Hellstrand K, Thorén FB. Blood. 2019 Jan 15. pii: blood-2018-09-874990. doi: 10.1182/blood-2018-09-874990. [Epub ahead of print] PMID: 30647027

More publications